A pair of pump and valve manufacturers have recently announced the adoption of a platform for spray analysis and pump-release testing provided by Proveris Scientific Corp. (Marlborough, MA).
Valois Pharma (Le Neubourg, France) and Ing. Erich Pfeiffer GmbH (Radolfzell, Germany) added Proveris’s solution, which incorporates an instrument service plan, software licensing, and software support and maintenance.
“We value the relationship with Valois Pharma and Pfeiffer because it allows us to support many current and future orally inhaled and nasal drug products (OINDP) projects,” said Zach Pitluk, vice president of commercialization at Proveris, in a press release. “Proveris respects the technology and innovativeness of Valois Pharma and Pfeiffer in the OINDP marketplace and looks forward to providing them with complete solutions for spray characterization and release testing.”
Valois Pharma, a division of Valois S.A.S., and Ing. Erich Pfeiffer GmbH are world leaders in nasal and pulmonary drug-delivery technologies with a range of innovative drug-delivery devices, technologies, and services.